Nalbuphine

Generic Name
Nalbuphine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C21H27NO4
CAS Number
20594-83-6
Unique Ingredient Identifier
L2T84IQI2K
Background

A narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors. Nalbuphine is the only opioid analgesic that is not a controlled substance in the United States.

Indication

For the relief of moderate to severe pain.

Associated Conditions
Severe Pain, Moderate Pain, Obstetrical analgesia therapy
Associated Therapies
Perioperative analgesia, Obstetric analgesia

Morphine and/or Nalbuphine as Adjuvants in Ultrasound Guided Interscalene Block: for Shoulder Surgeries

First Posted Date
2017-01-27
Last Posted Date
2017-05-22
Lead Sponsor
Assiut University
Target Recruit Count
80
Registration Number
NCT03034382
Locations
🇪🇬

Assiut University Hospitals, Assiut, Egypt

The Application of Transversus Abdominis Plane Block Plus Rectus Sheath Block in Clinical Anesthesia

First Posted Date
2016-12-07
Last Posted Date
2018-02-22
Lead Sponsor
The First Affiliated Hospital of Anhui Medical University
Target Recruit Count
190
Registration Number
NCT02984865
Locations
🇨🇳

the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

Non-anesthesiologist-administered Propofol During the Flexible Bronchoscopy

First Posted Date
2016-06-30
Last Posted Date
2024-12-02
Lead Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Target Recruit Count
102
Registration Number
NCT02820051
Locations
🇲🇽

UANL University Hospital, Monterrey, Nuevo León, Mexico

Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-02-10
Last Posted Date
2018-06-26
Lead Sponsor
Assiut University
Target Recruit Count
106
Registration Number
NCT02678585
Locations
🇪🇬

Assiut university hospital, Assiut, Egypt

Analgesia Effects of Nalbuphine vs Sulfentanil

First Posted Date
2015-11-13
Last Posted Date
2015-11-13
Lead Sponsor
Fudan University
Target Recruit Count
80
Registration Number
NCT02604797

Diclofenac Premedication, as the Effect of Preemptive Analgesia After Post-thoracotomy Chest and Shoulder Pain

First Posted Date
2015-05-15
Last Posted Date
2017-03-09
Lead Sponsor
University of Debrecen
Target Recruit Count
3
Registration Number
NCT02445599
Locations
🇭🇺

UNIVERSITY OF DEBRECEN FACULTY OF MEDICINE Department of Anesthesiology and Intensive Care, Debrecen, Hajdú-Bihar, Hungary

Herb Drug Interaction of Traditional Chinese Herb and Commonly Used Drugs

First Posted Date
2009-06-18
Last Posted Date
2009-06-19
Lead Sponsor
Tri-Service General Hospital
Target Recruit Count
50
Registration Number
NCT00923000
Locations
🇨🇳

Tri-Service General Hospital, Taipei, Taiwan

The Development of Oral Nalbuphine Dosage Form

Not Applicable
Conditions
Interventions
First Posted Date
2009-06-18
Last Posted Date
2009-06-19
Lead Sponsor
Tri-Service General Hospital
Target Recruit Count
60
Registration Number
NCT00924079
Locations
🇨🇳

Tri-Service General Hospitial, Taipei, Taiwan

Epidural Nalbuphine for Postcesarean Epidural Morphine Induced Pruritus

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-07-01
Last Posted Date
2008-07-08
Lead Sponsor
Mahidol University
Target Recruit Count
165
Registration Number
NCT00707824
Locations
🇹🇭

Mahidol University, Bangkoknoi, Bangkok, Thailand

Nalbuphine for the Treatment of Opioid Induced Pruritus in Children

Phase 3
Completed
Conditions
First Posted Date
2006-05-09
Last Posted Date
2008-09-25
Lead Sponsor
University of British Columbia
Target Recruit Count
134
Registration Number
NCT00323154
Locations
🇨🇦

British Columbia's Children's Hospital, Vancouver, British Columbia, Canada

© Copyright 2024. All Rights Reserved by MedPath